Enlivex Therapeutics Ltd(NASDAQ:ENLV) 
Enlivex Therapeutics Ltd. operates as a clinical stage macrophage reprogramming immunotherapy company. It is developing Allocetra, an off-the-shelf cell therapy designed to reprogram macrophages into homeostatic state. Resetting non-homeostatic macrophages into homeostatic state is critical for immu...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.92
H 0.93
L 0.85
C 0.89
V 104,011
10EMA 0.89
20EMA 0.89
60EMA 0.89
120EMA 0.89
250EMA 0.89